JPMorgan led with five ETFs, followed by Allianz, Bluebay, Comgest, Man and Morgan Stanley each with one mutual fund approved. Two alternative products also got the green light, one from Hollyport Capital and one from Rivean Capital.
CCR Monthly Approval Report – May 2024
BNP Paribas, Credicorp Capital, JP Morgan, Morgan Stanley, PIMCO, Theam Quant, Eurazeo and Kinderhook were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – April 2024
A total of 22 products were added in the month from six different asset managers: Aegon, Bradesco, Invesco, Moneda, Oaktree andTikehau.
CCR Monthly Approval Report – March 2024
A total of 11 products were added in the month from four different asset managers: iShares, Premier Miton, Robeco and InfraRed Capital Partners.
CCR Monthly Approval Report – February 2024
A total of five products were added in the month from five different asset managers: AllianceBernstein, Man, Pinebridge, Apollo, GI Partners, Monroe Capital and SLR CP.
CCR Monthly Approval Report – January 2024
Three mutual funds, one ETF and one alternative product gained CCR approval to kick off 2024. Sponsors gaining approval were UBS, Invesco and TrueBridge Capital Partners.
CCR Monthly Approval Report – December 2023
Barings, Gemcap, BNP Paribas, UBS andGlobal Infrastructure Partners were the fund sponsors gaining approval for new product
CCR Monthly Approval Report – November 2023
A total of 14 products were added in the month from the following asset managers: Vanguar, New Capital, Invesco, UTI Goldfinch, TowerBrook Capital Partners and Strategic Partners.
CCR Monthly Approval Report – October 2023
A total of six products were added in the month from six different asset managers: Franklin Templeton, Goldman Sachs, Impax, Jupiter, KPS Capital and Vanguard.
CCR Monthly Approval Report – September 2023
A total of five products were added in the month from four different brands: Franklin Templeton, Colchester, M&G, and Independencia.